🔗 Share this article Social Media Content Creators Driving Parallel Trade for Unlicensed Slimming Medication A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings. Experimental Treatment Gaining Popularity Online Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving discount codes. Thriving Trade on Messaging Platforms Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing buyers to WhatsApp for transactions. Learning About The Experimental Drug Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic. Medical Experts Voice Worries Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source. Some professionals stated the demand for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro. Regulatory Status and Implementation Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012. Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment. Platform Response and Material Removal According to TikTok, the service has taken down violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures. Online Trading Activities Investigations also found communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, filled with images of slimming results, glowing testimonials and detailed instructions for preparing or administering at residence. Within minutes of entering one community, a seller shared contact information, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience. Item Details and Pricing Inside these groups, messages show dark colored packages with Royal Mail labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”. Service Moderation and Security Measures A representative for the messaging service stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Cautions “People are injecting substances they cannot confirm. Even if the science behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained. Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.” Producer Statement A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose users to possibly significant health risks”.